Mind + Muscle

technical minds + legal muscle




While the term biotechnology originated largely in the 1970's after recombinant DNA techniques were invented, the industry has grown through divergent and convergent evolution.  The biotechnology practice at Sterne Kessler was established by Dr. Jorge Goldstein just as the biotech revolution was getting started.  As the market expanded so did our practice.  Today, our biotech practice is as diverse as the industry itself.  We counsel clients worldwide on intellectual property strategy across a wide variety of fields, intersecting with each of the four major applications of biotechnology -- medicine and healthcare, agricultural processes, non-food and industrial processes, and environmental uses.

We represent companies and research institutes of all sizes and levels, and they span, among others, the areas of:

  • Molecular and Cell Biology
  • Nanomedicine
  • Agrochemicals 
  • Pharmacogenomics 
  • Vaccines 
  • Bioprocessing and Biofuels 
  • Therapeutic Antibodies
  • Biodefense
  • Nutraceuticals
  • Biologics and Biosimilars

We prepare and prosecute patent applications before the U.S. and foreign patent offices, conduct interferences, oppositions, arbitrations, and litigations (both as counsel and expert witnesses and at all court levels). For those collaborating, licensing or commercializing innovations, we provide counseling regarding agreements and develop freedom to operate opinions. Additionally, we conduct intellectual property due diligence to support our clients who are licensing or investing in promising new technologies.

We meet your needs with a sophisticated team of more than 70 attorneys and technical staff, most have advanced training that cuts across a variety of disciplines including:

  • Biochemistry
  • Bioinformatics
  • Computer-aided Drug Design
  • Enzymology
  • Food Science
  • Gene Therapy
  • Genetics
  • Genomics
  • Immunology
  • Medicinal Chemistry
  • Microbiology
  • Molecular Biology
  • Organic Chemistry
  • Pharmacology
  • Physical Chemistry
  • Plant Genetics
  • Virology

This technical expertise combined with 30 years of practice in the legal field makes Sterne Kessler one of the most experienced biotechnology IP practices in the nation, if not the world.

(1) Related People

(3) The Financial Times’ 2015 Most Innovative Law Firm for Social Responsibility

A Case Study:

The Financial Times’ 2015 Most Innovative Law Firm for Social Responsibility

Sterne Kessler is pleased to announce that the firm's Intellectual Property and Human Rights Pro Bono practice has been recognized as the winner of the Financial Times' Most Innovative North American Lawyers 2015 award in the category of "Innovation in a Social Responsibility Project," with special commendation to director and pro bono practice leader Jorge Goldstein.


Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.